SAT-1150 Determining the Importance of Aspartate and Methionine Amino Acids Carboxyl of the RGD Motif in Recombinant Mojastin Disintegrins in Apoptotic Induction

Saturday, October 13, 2012: 12:20 AM
Hall 4E/F (WSCC)
Rafael Medrano , Biological Sciences, San Jose State University, San Jose, CA
Daniel Gutierrez , Biological Sciences, San Jose State University, San Jose, CA
David Carrillo , Biological Sciences, San Jose State University, San Jose, CA
Julio Soto, PhD , San Jose State University, San Jose, CA
Integrins are cell surface receptors that play an important role in apoptotic induction. Disintegrins are small peptides, from viper venom, containing a binding motif composed of the amino acids arginine (R), glycine (G) and aspartate (D). This tripeptide motif has a high affinity to the integrin-binding site. Previous research has shown that recombinant mojastin (r-Moj) disintegrins with the amino acids D and M immediately carboxyl to the RGD motif induce apoptosis of a human melanoma cell line (SK-Mel-28). I am testing two hypotheses. First hypothesis: recombinant disintegrins with a D amino acid following the RGD (RGDD) will induce apoptosis of SK-Mel-28 cells. Second hypothesis: recombinant disintegrins with an M amino acid following the RGD (RGD_M) will induce apoptosis of SK-Mel-28 cells. Five mojastin mutants were obtained (r-Moj-DA, r-Moj-DG, r-Moj-DV, r-Moj-NM, and r-Moj-WM) to test these hypotheses by site directed mutagenesis. Chromatin fragmentation was used to determine if r-Moj-DA, r-Moj-NM, and r-Moj-WM induce apoptosis of SK-Mel-28. For this method, SK-MEL-28 cells were grown on chambered slides and treated with 5 µM of the peptides for 24 hr. Treated cells were stained with Hoechst and visualized under a Zeiss fluorescent microscope. Preliminary results indicated that r-Moj-DA, r-Moj-NM, and r-Moj-WM induced apoptosis. Chromatin fragmentation will be performed with r-Moj-DG and r-Moj-DV. TUNEL assays will be performed with all the recombinant peptides to measure the number of cells undergoing apoptosis after treatment. This project was funded by NSF-REU grant DBI 1004350.